QUOTE AND NEWS
SeekingAlpha  Mar 12  Comment 
By Stephen Simpson, CFA: Wright Medical's (WMGI) acquisition of BioMimetic Therapeutics and its Augment biological product for bone healing has been almost nothing but trouble. At seemingly every turn the FDA has thrown up obstacles to Augment,...
TechCrunch  Aug 15  Comment 
Today in our continuing series entitled "Robots That Will Eventually Drink The Liquid From Your Eyeball In Your Sleep" we present the STAR.V3, a superfast, 3D-printed robot that can squeeze itself down to fit underneath a door and/or scuttle...
StreetInsider.com  Mar 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Wright+Medical+Group+%28WMGI%29+Completes+%24380M+Acquisition+of+BioMimetic/8145656.html for the full story.
StreetInsider.com  Feb 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Receives+Informal+Request+from+FDA+for+Augment+PMA/8059289.html for the full story.
StreetInsider.com  Jan 14  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Says+Class+Action+Suit+Dismissed+in+Tennessee/8004880.html for the full story.
StreetInsider.com  Jan 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioMimetic+%28BMTI%29+Initiates+Phase+II+for+ACT+as+Lateral+Epicondylitis+Treatment/7980282.html for the full story.
Benzinga  Nov 21  Comment 
In a report published Wednesday, Loewen Ondaatje McCutcheon downgraded its rating on BioMimetic Therapeutics (NASDAQ: BMTI) from Buy to Hold, but reiterated its $7.50 price target. Loewen Ondaatje McCutcheon noted, “With BMTI trading within...
Benzinga  Nov 19  Comment 
In a report published Monday, Loewen Ondaatje McCutcheon reiterated its Buy rating and $7.50 price target on BioMimetic Therapeutics (NASDAQ: BMTI). Loewen Ondaatje McCutcheon noted, “Overall, our views are mixed on the acquisition of BMTI by...
StreetInsider.com  Nov 19  Comment 
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) 69.0% HIGHER; Wright Medical (Nasdaq: WMGI) will acquire BioMimetic in a $380 million deal. CAMAC Energy Inc. (AMEX: CAK) 21.5% HIGHER; Chairman and CEO, Dr. Kase Lawal, has adopted a prearranged...
Wall Street Journal  Nov 19  Comment 
Among the companies with shares expected to actively trade in Monday's session are BioMimetic Therapeutics, Diamond Foods and Lowe's.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki